凝胶渗透色谱-气相色谱-质谱法测定人乳中卤代有机化合物

建立了用凝胶渗透色谱(GPC)去脂、气相色谱-负化学电离源-质谱(GC-NCI-MS)测定人乳中多溴联苯醚(PBDEs)、德克隆(DP,包括syn-DP和anti-DP)、五溴甲苯(PBT)、六溴苯(HBB)和多氯联苯(PCBs)的方法。人乳样品中加入内标13C12-BDE-139、13C12-BDE-209、13C10-syn-DP、13C12-PCBs(13C12-CB-81,77,123,118,114,105,126,167,156,157,169,189),空白样品还额外加入PBT和HBB,经过加酸去蛋白质、液液萃取、GPC去脂、酸性硅胶柱净化后,定量测定。人乳样品中13C12-BDE-139、13C12-BDE-209、13C10-syn-DP、13C12-PCBs的加标回收率分别为112.9%±14.0%、99.3%±12.7%、80.5%±17.9%、64.6%±2.4%,空白样品中PBT和HBB的加标回收率分别为102.8%±18.0%和88.1%±14.4%,各卤代化合物检出限范围为0.33~333.3pg/m L。应用本方法对人乳样品进行检测,均没有检出CB-77,81,169、BDE-154,85、syn-DP、anti-DP。∑9PCBs(CB-123,118,114,105,126,167,156,157,189)、∑8PBDEs(BDE-28,47,100,99,153,183,190,209)、PBT、HBB浓度范围分别为:0.11~0.22、4.9~7.9、0.0037~0.0056和0.0053~0.021ng/m L。     

界面扩张流变法研究C12mimBr对Gemini12-2-12在空气/水界面聚集行为的影响

采用界面扩张流变技术研究了季铵盐偶联表面活性剂C₁₂-(CH₂)₂-C₁₂·2Br (Gemini12-2-12)及其与离子液体表面活性剂溴化1-十二烷基-3-甲基咪唑(C₁₂mimBr)复配体系的动态界面张力、扩张流变性质和界面弛豫过程等, 探讨了C₁₂mimBr 对C₁₂mimBr/Gemini12-2-12 混合体系界面性质的影响及C₁₂mimBr 对Gemini12-2-12界面聚集行为影响的机制. 结果表明, 随着离子液体表面活性剂的不断引入, 体系界面吸附达到平衡所需的时间逐渐缩短, 扩张模量和相角明显降低, 界面吸附膜由粘弹性膜转变为近似纯弹性膜; 同时, 界面及其附近的弛豫过程也发生显著变化, 慢弛豫过程消失, 快弛豫过程占主导地位, 且离子液体浓度越高, 快弛豫的贡献越大. 这些界面性质的变化主要归因于离子液体表面活性剂C₁₂mimBr参与界面形成及两表面活性剂在界面竞争吸附的结果. 少量离子液体表面活性剂C₁₂mimBr 的加入可以填补疏松的Gemini12-2-12 界面上的空位, 形成混合界面吸附膜. 随着C₁₂mimBr 含量的增加, 嵌入界面的C₁₂mimBr 分子数不断增多, 导致界面上相互缠绕的Gemini12-2-12烷基链“解缠”, 在体相和界面分子扩散交换的过程中“解缠”的Gemini12-2-12分子从界面上解吸回到体相, 与此同时, C₁₂mimBr 分子相对较小的空间位阻及较强的疏水作用促使其优先扩散至界面进而取代Gemini12-2-12分子, 最终界面几乎完全被C₁₂mimBr分子所占据.     

新型N-甲基-N-(2-溴苯基)-2-取代基-2-氰基酰胺的合成

以2-溴苯胺和氰乙酸为原料,经N-烷基化、酰胺化和α-烷基化反应合成了4种新型的N-甲基-N-(2-溴苯基)-2-取代基-2-氰基酰胺类化合物(5a~5d),其结构经1H NMR,13C NMR和HR-MS表征。在最佳反应条件[N-甲基-N-(2-溴苯基)-2-氰基乙酰胺(3)1.7 mmol,n(3)∶n(溴乙烷)=1∶1,DMF为溶剂,Cs2CO3为碱,于室温反应6 h]下,5a收率83%。     

7,7-二甲基-2-对溴苯基-4-苯基-5-氧代-1,4,5,6,7,8-六氢化-6H-喹啉的合成及晶体结构

标题化合物C23H22BrNO是由1-(4-溴苯基)-3-苯基-2-丙烯-1-酮与5,5-二甲基-1, 3-环己二酮在N, N-二甲基甲酰胺(DMF)中在NH4OAc催化下反应而得。结构通过单晶X-射线衍射分析确定,其晶体属于单斜晶系,空间群C2/C, a = 19.678(4),b = 13.571(2),c = 17.311(3) 牛琤 = 118.74(1),Mr = 408.33, V = 4055(1) ?,Dc = 1.338 g/cm3, Z = 8, m (MoKa) = 2.038 mm-1, F(000) = 1680, R = 0.0539,wR = 0.1369。X-衍射分析表明,六元环C(10)C(13)C(16)C(17)采用半椅式构象:原子C(10),C(11),C(12),C(16)和C(17)在同一个平面内,而原子C(13)远离平面为0.3282 牛闷矫嬗?个苯环的夹角分别为41.09, 81.97,2个苯环的夹角为75.87。另外在晶体结构中,存在1个分子间氢键。     

新型5-溴嘧啶衍生物的选择性合成

对甲苯磺酰氯与三甘醇单甲酯完成酯化反应,再与对溴苯酚缩合制得对溴苯基三甘醇单甲醚(3);3与硼酸甲酯完成取代反应、酸解后在Pd(PPh3)4催化下与5-溴-2-碘嘧啶(5)在甲苯中通过Suzuki偶联反应选择性地合成了5-溴-2-对(甲基三甘醇基)苯基嘧啶(1a),收率73%。以1-十二烯和5为主要原料,通过Suzuki偶联反应,一锅法选择性地合成了5-溴-2-十二烷基嘧啶(1b),收率82%。1a和1b未见文献报道,其结构经1HNMR,13C NMR和MS表征。     

α-(异吲哚啉酮-2-基)戊二酰亚胺含氟类似物的合成与白血病细胞K562抑制活性

以L-谷氨酰胺为原料,经氨基保护、缩合闭环、氨基脱保护得中间体3-氨基-2,6-哌啶二酮盐酸盐(4),另以不同的2-甲基-硝基苯甲酸甲酯为原料,经硝基还原、Balz-Schiemann反应、硝化反应、溴化反应得一系列2-溴甲基苯甲酸甲酯衍生物9a~9d和12a~12b;4与不同的2-溴甲基苯甲酸甲酯衍生物在弱碱下反应得到了一系列新的α-(异吲哚啉酮-2-基)戊二酰亚胺含氟类似物10a~10d,13a~13b和15;13a和13b经硝基还原得两个目标化合物14a和14b.合成化合物的结构经1H NMR和HRMS确证.用噻唑蓝(MTT)法测试了7个目标化合物对白血病细胞株K562的抑制活性,结果表明,化合物10a对K562细胞的抑制作用与来那度胺相当;化合物15对K562细胞具有较强的抑制作用,在25?g/m L浓度下抑制率达99%.     

(Z)-4-(2-溴乙烯基)苯磺酸酚酯的“一锅法”合成

以3-(4-氯磺酰苯基)-2,3-二溴丙酸和酚为原料,以CH2C12-DMF(v/v:2/1)为混和溶剂,加入Et3N,在0℃-室温条件下“一锅法”反应12h,即可高立体选择性地合成(Z)4-(2-溴乙烯基)苯磺酸酚酯(Z/E:＞99/1),收率78.5-81.0％.该化合物可以简便的转化为(Z)-4-(2-溴乙烯基)...     

3-羰基-10-去甲基-12-甲氧基-13-甲基罗汉松烷的全合成

以1,3-环己二酮为原料,经过甲基化反应和羰基保护构筑了A环合成子(5)。以邻甲基苯甲醚为原料,对位溴代、与环氧乙烷加成和进一步溴代等反应合成了C环合成子(9)。化合物5与9的格氏试剂偶联和关环反应完成目标产物3-羰基-10-去甲基-12-甲氧基-13-甲基罗汉松烷(11)的全合成。各中间体及目标产物结构均经红外光谱、核磁、质谱等表征,结果表明,成功实现了目标产物的合成。     

Claisen重排反应合成5-烯丙基-4-羟基异吲哚啉-2-羧酸叔丁酯

以2,3-二甲基苯酚(2)和烯丙基溴为原料,经过醚化、溴代、关环及Claisen重排等四步反应,合成得到5-烯丙基-4-羟基异吲哚啉-2-羧酸叔丁酯(1),4步反应总收率为17.8％.中间体及产物结构经1 H NMR和ESI-MS表征,产物结构进一步经过FT-IR、13 C NMR及X-射线单晶衍射进行确认.同时,重点...     

(E)-4-硫-5-(2-溴乙烯基)尿苷/脱氧尿苷的合成及细胞毒性评价

以尿苷(1a)或2'-脱氧尿苷(1b)类化合物为原料,经碘代、选择性氧化、Heck反应等步骤快捷、环保地合成(E)-5-(2-溴乙烯基)尿苷/(E)-5-(2-溴乙烯基)-2'-脱氧尿苷(5a/5b),再通过酯化、硫羰基化、氨解等步骤合成新化合物(E)-4-硫-5-(2-溴乙烯基)尿苷/(E)-4-硫-5-(2-溴乙烯基)-2'-脱氧尿苷(8a/8b),共得到5种新的硫代产物,其中包含2种新产物8a/8b,3种新中间体7a,7b,10.其结构通过~1H NMR,~(13)C NMR,IR,UV,HRMS,X-Ray等谱图手段进行了表征.采用3-(4,5-二甲基-2-噻唑基)-2,5-二苯基-2H-溴化四唑(MTT)实验方法对8a及其类似物进行了细胞毒性评价,发现8a/8b是潜在的抗肿瘤药物.     

同位素稀释热电离质谱法测定人血清中痕量铜和锌

采用热电离同位素稀释质谱法(ID-TIMS)准确测定了欧盟标准物质与测量研究院(EC-JRC-IRMM)组织的国际测量评估计划IMEP-17人血清样品中的痕量铜和锌。由于锌和铜都是易受污染的元素,本工作建立了仅用少量硝酸消解的低流程本底和适于热电离质谱测量的生物基体血清中痕量铜和锌的样品前处理方法;采用适当比例的硅胶和磷酸作为电离增强剂,在热电离质谱(TIMS)测量时获得了较高强度且稳定的铜和锌离子束;血清中痕量铜和锌的测量结果可直接溯源到国际单位mole。2种人血清样品中铜和锌测量结果的不确定度(k=2)分别为0.94%、0.83%和0.49%,测量值被EC-JRC-IRMM采用作为该样品的标准值。     

The Detection of Two Lithium Species in the Blood Serum of Mental Patients

Abstract

Li FT-NMR was used for the detection of different lithium species in human serum. Two serum samples from mentally ill patients undergoing lithium treatment were studied. Both samples gave spectra with a major peak corresponding to aqueous lithium ion and a much smaller peak at ?0.3 ppm relative to the lithium ion peak. Two serum samples from normal persons were spiked with lithium but the resulting spectra showed only the lithium ion peak.     

Elevated levels of hydroxylated phosphocholine lipids in the blood serum of breast cancer patients

The difference in serum phospholipid content between stage‐IV breast cancer patients and disease‐free individuals was studied by employing a combination of chemometric statistical analysis tools and mass spectrometry. Chloroform‐extracted serum samples were profiled for their lipid class composition and structure using precursor ion, neutral loss, and product ion tandem mass spectrometric (MS/MS) scanning experiments. Changes in the relative abundance of phospholipids in serum as a consequence of cancer progression, measured through electrospray ionization (ESI) mass spectrometry of flow‐injected serum samples collected from 25 disease‐free individuals and 50 patients diagnosed with stage‐IV breast cancer, were statistically evaluated using principal component analysis (PCA), analysis of variance (ANOVA) and receiver operating characteristic (ROC) analysis. Lipids whose abundance changed significantly as a consequence of cancer progression were structurally characterized using product ion spectra, and independently quantified using precursor ion scan experiments against an internal standard of known concentration. Phosphocholine lipids that displayed a statistically significant change as a consequence of cancer progression were found to contain an oxidized fatty acid moiety as determined by MS³ experiments. Copyright © 2009 John Wiley & Sons, Ltd.     

Integrated multi-sensor chip with photocured polymer membranes containing copolymerised plasticizer for direct pH, potassium, sodium and chloride ions determination in blood serum

An analytical system based on a sensor array with ion-selective field effect transistors (ISFETs) monolithically integrated in one chip covered with photocured polymer membranes containing copolymerised plasticizer and a sequential injection analysis (SIA) is shown to offer an automation of the analysis of blood serum components. For sequential injection system a custom made dual channel flow cell for the sensor array was developed. Optimisation of ion-sensitive membrane characteristics and calibration solution compositions were carried out. The system was used to analyze sodium, potassium, chloride ion contents in blood serum samples. The precision of the ion determination in samples was typical for potentiometic method with standard deviation of about 3-5%.     

Determination of the ubiquinol-10 and ubiquinone-10 (coenzyme Q10) in human serum by liquid chromatography tandem mass spectrometry to evaluate the oxidative stress

A method for the rapid and simultaneous determination of ubiquinone-10 (coenzyme Q10, CoQ(10)) and the reduced form ubiquinol-10 (CoQ(10)H(2)) in human serum by LC-MS-MS with electrospray ionization (ESI) in the positive mode is here proposed. High selective identification and sensitive quantitation of both analytes have been carried out by monitoring the transition from the corresponding precursor ion to the product ion. Prior to the chromatographic analysis, serum samples (100 microl) were subject to a conventional pre-treatment based on protein precipitation, liquid-liquid extraction, evaporation to dryness and reconstitution with 95:5 methanol/hexane (v/v). The overall method has enabled to achieve low detection limits--5.49 and 15.8 ng/ml for CoQ(10) and CoQ(10)H(2), respectively--which were estimated with serum. The accuracy and potential matrix effects have been studied with spiked serum resulting recoveries between 92.82 and 106.97%. The proposed method has been applied to serum samples from healthy middle-age women, in which the CoQ(10)H(2)/CoQ(10) ratio has been used as marker of oxidative stress.     

Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: A strategy to distinguish patients with preeclampsia from matching control individuals

A multifactorial differential analysis of serum proteins using mass spectrometry distinguished samples from pregnant women with severe early-onset preeclampsia (n = 11) from those of control individuals with uneventful pregnancies (n = 13). Serum proteins were fractionated by either their affinities to reversed-phase material coated magnetic beads or by fractionated precipitation. The on-average most abundant ion signals were observed at m/z 9390, 9103, and 8886. The best differentiating ion signals between the two sample groups were found at m/z 13,715, 13,834, and 13,891. The normalized intensities of these ion signals were on-average lower in the preeclampsia group than in the control group. The six ion signal intensities enabled sorting of the individual spectra with high accuracy. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis showed that a protein band migrating just above the 14 kDa marker band contained transthyretin (P02766; Mr (avg.): 13,761). Densitometric analysis of the transthyretin bands showed lower intensities in the preeclampsia samples with respect to those of the controls. Nephelometric analysis of the serum samples determined the mean concentration of transthyretin in the preeclampsia group were lower (0.16 mg/mL; range: 0.13 to 0.20; SD: 0.03) than that in the control group (0.19 mg/mL; range: 0.14 to 0.22; SD: 0.02), substantiating the role of transthyretin concentration differences in the comparison of the two groups. Altogether, our findings support the theory of preeclampsia being a heterogeneous disorder that might be sub-classified by a defined proteome signature in maternal blood using multifactorial analysis of affinity-fractionated serum samples.     

UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: Effect of experimental artefacts and anticoagulant

Clotting and anticoagulation of blood samples may give rise to different metabolic profiles of serum and plasma samples, respectively. The anticoagulant used for blood plasma preparation may affect the resulting metabolic profile due to different mechanisms involved in anticoagulation by various agents, e.g. heparin, EDTA and citrate. In the present study, we looked into metabolite and other differences in matched serum and plasma samples and different plasma preparations by using untargeted UPLC-ESI-QTOF/MS profiling and multivariate data analysis (PCA and OPLS-DA). Metabolite differences between serum and plasma samples were mainly related to small peptides reflecting presence or absence of coagulation. Only subtle metabolite differences between the different plasma preparations were noticed, which were primarily related to ion suppression or enhancement caused by citrate and EDTA anticoagulants. For the first time, we also report that anticoagulant counter cation (Na+ or K+) in Na-citrate and K-EDTA plasma can make some metabolites more dominant in ESI-MS. Polymeric material residues originating from blood collection tubes for serum preparation were observed only in serum samples. Hypoxanthine and xanthine were found at higher levels in serum than in plasma samples, possibly due to release from the clot. Mass spectral features of sodium formate and potassium formate ion clusters were detected in citrate and EDTA plasma samples, respectively, originating from formate in mobile phase and Na⁺ (in Na-citrate tubes) and K⁺ (in K-EDTA tubes). Among the anticoagulants, heparin is recommended for plasma samples used for LC-ESI/MS-based metabolomics of hydrophilic compounds because no plasma interferences or matrix effects were noticed for this polarity range. Citrate and EDTA should be avoided since interferences and serious matrix effects were encountered on some co-eluting polar metabolites. Serum is recommended as a second choice and an alternative to plasma. In conclusion, heparin plasma or serum should be the order of best choice for LC-ESI/MS-based metabolomics research.     

Measurement of bisphenol A in human serum by gas chromatography/mass spectrometry

The purpose of this study is to establish an easy and accurate method for the determination of bisphenol A (BPA) in the human serum. The samples were applied to the C₁₈ solid phase extraction (SPE) column for clean up of samples. The BPA is conjugated with tetrabutylammonium hydrogen sulfate as the counter ion in alkali solution. The ion paired BPA is moves from the aqueous phase to the organic phase as an ion paired extraction. BPA extracted from human serum were derivatized with pentafluorobenzyl bromide (PFBBr). The derivative was analyzed by gas chromatography (GC)/mass spectrometry (MS) using negative chemical ionization (NCI). The instrumental detection limit of BPA was 5 pg/ml (10 fg). The instrumental response between 0.01 and 100 pg/ml of BPA standards was linear (r²=0.998). The recovery of BPA spiked into human serum was 101.0±4.63 (1 pg/ml) and 100.9±3.75 (10 pg/ml), respectively. The concentration of BPA in the human serum from 20 individuals was 0.54 pg/ml.     

血清中尿酸和尿素含量测定的超高效液相色谱–单四级杆质谱法国际比对

基于单四极杆质谱建立了血清中尿酸、尿素含量准确测定的同位素稀释超高效液相色谱–质谱方法,并以该方法参加了国际物质量咨询委员会(CCQM)组织的"血清中尿酸尿素含量测定"的K、P国际比对。血清样品用乙腈除去蛋白质,分别采用C18反相柱和电喷雾(ESI)负离子模式检测尿酸、CN正相柱和ESI正离子模式检测尿素,同位素稀释的单点校准法进行定量,用3种标准物质(GBW 09157,GBW 09169,NIST SRM 909c)进行方法验证,测量比对血清样品(Ⅰ,Ⅱ)获得国际等效一致性。该方法操作简单、快速准确,适用于血清中尿酸尿素的定量分析。     

Determination of Nickel,Manganese, Copper and Zinc in Blood Serum by Atomic Absorption Spectrometry after Deproteinization by Microwave Irradiation

ABSTRACT

Deproteinization of serum was performed by microwave irradiation combined with a small volume of diluted trichloracetic acid. The procedure reduced the protein level of the samples to less than 99% of the total with a small dilution factor (1+1) and allowed the determination of nickel and manganese by electrothermal atomic absorption spectrometry and copper and zinc by flame atomic absorption spectrometry directly without modifiers or matrix interferences. As metallic ions are normally bonded to serum proteins they must be released during protein precipitation. Spiked serum samples were submitted, before the deproteinization, to an incubation treatment to bond the added ions to the proteins. To check the efficiency of the incubation time for each ion, serum samples were ultrafiltered at set time intervals and the metals determined in the ultrafiltrate. The proposed method was compared with the common deproteinization by acids for the separation of the proteins. The reduction of proteins allowed a small dilution of the sample and the use of faster temperature programmes for the determination of nickel and manganese by electrothermal atomic absorption spectrometry and the aspiration of samples more similar to aqueous standards for copper and zinc determination by flame atomic absorption spectrometry. Recoveries from spiked, incubated and deproteinized samples compared to only diluted samples show that the method can satisfactorily be used for atomic absorption spectrometric determination of these elements.